Pivot Pharmaceuticals

Pivot Pharmaceuticals

Pharmaceuticals, Woburn, Massachusetts, 01801, United States, 1-10 Employees

pivotpharma.com

  • twitter
  • LinkedIn

Who is PIVOT PHARMACEUTICALS

Pivot Pharmaceuticals is an emerging biotechnology company engaged in the development of novel therapeutics to treat unmet medical needs to improve womens health. It has developed a pipel...

Read More

map
  • Woburn, Massachusetts, 01801, United States Headquarters: Woburn, Massachusetts, 01801, United States
  • 2014 Date Founded: 2014
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

checked-icon Does something look wrong? Fix it. | View contact records from PIVOT PHARMACEUTICALS

Pivot Pharmaceuticals Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Pivot Pharmaceuticals

Answer: Pivot Pharmaceuticals's headquarters are located at Woburn, Massachusetts, 01801, United States

Answer: Pivot Pharmaceuticals's official website is https://pivotpharma.com

Answer: Pivot Pharmaceuticals's revenue is Under $1 Million

Answer: Pivot Pharmaceuticals has 1-10 employees

Answer: Pivot Pharmaceuticals is in Pharmaceuticals

Answer: Pivot Pharmaceuticals contact info: Phone number: Website: https://pivotpharma.com

Answer: Pivot Pharmaceuticals is an emerging biotechnology company engaged in the development of novel therapeutics to treat unmet medical needs to improve womens health. It has developed a pipeline of drug candidates for the treatment of unmet needs in womens cancers by acquiring a novel portfolio of anticancer drugs targeting a novel mechanism to treat gynecological and triple-negative breast cancers. The Company will treat gynecological disturbances by repurposing approved drugs with proprietary technologies to create a pipeline of novel therapeutics. The company has developed an accelerated time to market strategy to enable commercializing the first of many new therapies by 2019.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access